Enhanced Expression of <i>miR-181b</i> in B Cells of CLL Improves the Anti-Tumor Cytotoxic T Cell Response
The clinical progression of B cell chronic lymphocytic leukemia (CLL) is associated with immune cell dysfunction and a strong decrease of <i>miR-181b-5p</i> (<i>miR-181b</i>), promoting the death of CLL cells. Here we investigated whether the reduction of <i>miR-181b<...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/2/257 |